Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Testis-specific linker histone H1.6 (H1T) is a structural chromatin protein in humans, encoded by the *H1-6* gene (formerly H1T)[3]. It is one of several non-allelic H1 histone variants and is notably expressed during spermatogenesis, where it forms a less compacted chromatin structure compared to somatic H1 isoforms, facilitating meiosis-related chromatin reorganization[3]. In general, linker histones such as H1.6 bind to the "linker DNA" between nucleosomal core particles, stabilizing both nucleosome structure and higher-order chromatin architecture[1][3][5]. Unlike the core histones (H2A, H2B, H3, H4), H1 binds outside the nucleosome core and is critical for chromatin compaction, nucleosome spacing, and gene expression regulation[2]. Mammalian genomes encode multiple H1 isoforms with specialized and sometimes partially redundant functions, and H1.6 is unique for its testis-predominant expression and functional role during sperm development[3]. There are no current drugs, biomarkers, or specific therapeutic implications associated with H1.6, and it is not regarded in pharmacology as a primary therapeutic target[3][5]. H1 variants, including H1.6, show differences in post-translational modifications, including phosphorylation, acetylation, and methylation, which modulate their binding and regulatory functions[5]. While some histone subtypes are implicated in epigenetic regulation involved in cancer and development, H1.6 is mostly studied in the context of germ cell differentiation[3][5]. The *H1-6* gene is located in the human chromosome 6 histone cluster and is intronless, typical of replication-dependent histone genes[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Testis-specific linker histone H1.6 (H1.6 (also H1T)).